Endothelial dysfunction in spontaneously hypertensive rats: Consequences of chronic treatment with losartan or captopril

Journal of Hypertension

Volumn 15, Issue 6, 1997, Pages 613-618

  Rodrigo, Elena ^a   Maeso, Rosaura ^a   Muñoz García, Raquel ^a   Navarro Cid, Josefa ^a   Ruilope, Luis M ^b   Cachofeiro, Victoria ^a   Lahera, Vicente ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

Author keywords

Angiotensin converting enzyme inhibitors; Angiotensin II receptor antagonists; Endothelium derived contracting factor; Hypertension; Nitric oxide

Indexed keywords

15 HYDROXY 11ALPHA,9ALPHA EPOXYMETHANOPROSTA 5,13 DIENOIC ACID; ACETYLCHOLINE; ANGIOTENSIN; ANTIHYPERTENSIVE AGENT; CAPTOPRIL; ENDOTHELIN 1; ENDOTHELIUM DERIVED CONSTRICTING FACTOR; LOSARTAN; N(G) NITROARGININE METHYL ESTER; PHENYLEPHRINE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTA; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; HYPERTENSION; LONG TERM CARE; MALE; NONHUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RAT; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE RELAXATION; SPONTANEOUSLY HYPERTENSIVE RAT; SYSTOLIC BLOOD PRESSURE; VASCULAR ENDOTHELIUM; VASCULAR SMOOTH MUSCLE;

EID: 0030958794     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/00004872-199715060-00007     Document Type: Article

References (34)

1. Furchgott RF, Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 1980, 299:373-376.
2. Palmer RMJ, Ferrige AG, Moncada S: Nitric oxide release accounts for the biological activity of endothelium-derived relaxing factor. Nature 1987, 327:524-526.
3. Yanagisawa M, Kurihara H, Kimura S, Tomobe Y, Kobayashi M, Mitsui Y, et al.: A novel potent vasoconstrictor peptide produced by vascular endothelial cells. Nature 1988, 332:411-415.
4. 2, and prostacyclin. Pharmacol Rev 1978, 30:293-331.
5. Lüscher TF, Boulanger CM, Dohi Y, Yang Z: Endothelium-derived contracting factors. Hypertension 1992, 19:117-130.
6. De Mey JG, Gray SD: Endothelium-dependent reactivity in resistance vessels. Prog Appl Microcirc 1985, 88:181-187.
7. Tesmafariam B, Halpern W: Endothelium-dependent and endothelium-independent vasodilators in resistance arteries from hypertensive rats. Hypertension 1988, 11:440-444.
8. Lüscher TF, Vanhoutte PM: Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension 1986, 8:344-348.
9. Linder L, Kiowki W, Bühler FRR, Lüscher TF: Indirect evidence for release of endothelium-derived relaxing factor in human forearm circulation in vivo: blunted response in essential hypertension. Circulation 1990, 81:1762-1767.
10. Panza JA, Casino PR, Kilcoyne RN, Quyyumi AA: Role of endothelium-derived nitric oxide in the abnormal endothelium-dependent vascular relaxation of patients with essential hypertension. Circulation 1993, 87:1468-1474.
11. Taddei S, Virdis A, Mattei P, Salvetti A: Vasodilation to acetylcholine in primary and secondary forms of human essential hypertension. Hypertension 1993, 21:929-933.
12. Dohi Y, Criscione L, Pfeiffer K, Lüscher TF: Angiotensin blockade or calcium antagonists improve endothelial dysfunction in hypertension: studies in perfused mesenteric resistance arteries. J Cardiovasc Pharmacol 1994, 24:372-379.
13. Bennett MA, Hillier C, Thurston H: Endothelium dependent relaxation in resistance arteries from spontaneously hypertensive rats: effect of long term treatment with perindopril, quinapril, hydralazine or amlodipine. J Hypertens 1996, 14:389-397.
14. Diederich D, Yang Z, Bühler FR, Lüscher TF: Impaired endothelium-dependent relaxations in hypertensive resistance arteries involve the cyclooxygenase pathway. Am J Physiol 1990, 258:H445-H451.
15. 2 may be the endothelium-derived constrictor factor released by acetylcholine in the aorta of the rat. Hypertension 1990, 15:475-481.
16. Küng CF, Lüscher TF: Different mechanisms of endothelial dysfunction with aging and hypertension in rat aorta. Hypertension 1995, 25:194-200.
17. Tesfamariam B, Ogletree ML: Dissociation of endothelial cell dysfunction and blood pressure in SHR. Am J Physiol 1995, 269:H189-H194.
18. Timmermans PBMWM, Wong PC, Chiu AT, Herblin WF, Benfield P, Carini DJ, et al.: Angiotensin II receptors and angiotensin II receptor antagonists. Pharmacol Rev 1993, 45:205-251.
19. 2 receptors. Hypertension 1996, 28:967-972.
20. Jaiswal N, Diz DI, Chapell MC, Khosla MC, Ferrario CM: Stimulation of endothelial cell prostaglandin production by angiotensin peptides. Hypertension 1992, 19 (suppl II):II49-II55.
21. Goehlke P, Linz W, Schölkens BA, Wiemer G, Unger T: Cardiac and vascular effects of long-term losartan treatment in stroke-prone spontaneously hypertensive rats. Hypertension 1996, 28:397-402.
22. Cachofeiro V, Maeso R, Rodrigo B, Navarro J, Ruilope LM, Lahera V: Nitric oxide and prostaglandins in the prolonged effects of losartan and ramipril in hypertension. Hypertension 1995, 26:236-243.
23. 2 receptors, prostaglandins, kinins and nitric oxide. J Hypertens 1995, 13:1779-1784.
24. Manabe K, Shirase H, Usui H, Kurahashi K, Fujiwara M: Endothelium-dependent contractions induced by angiotensin I and angiotensin II in canine cerebral artery. J Pharmacol Exp Ther 1989, 251:317-320.
25. Grunfeld S, Hamilton CA, Mesaros S, McClain SW, Dominiczak AF, Bohr DF, et al.: Role of superoxide in the depressed nitric oxide production by the endothelium of genetically hypertensive rats. Hypertension 1995, 26:854-857.
26. Sunman W, Hughes AD, Sever PS: Free-radial scavengers, thiol-containing reagents and endothelium-dependent relaxation in isolated rat and human resistance arteries. Clin Sci 1993, 84:287-295.
27. Goldschmidt JE, Tallarida RJ: Pharmacological evidence that captopril possesses an endothelium-dependent component of vasodilation: effect of sulfhydryl groups on endothelium-derived relaxing factor. J Pharmacol Exp Therap 1991, 257:1136-1145.
28. Auerswald W, Doleschel W: On the potentiation of kinins by sulfhydrylic compounds. Arch Int Pharmacol 1967, 168:183-197.
29. Lahera V, Khraibi AA, Romero JC: Sulfhydryl group donors potentiate the hypotensive effect of acetylcholine in rats. Hypertension 1993, 22:156-160.
30. Qiu HY, Henrion D, Levy BI: Endogenous angiotensin II enhances phenylephrine induced tone in hypertensive rats. Hypertension 1994, 24:317-321.
31. Heagerty AM: Angiotensin II: Vasoconstrictor or growth factor? J Cardiovasc Pharmacol 1991, 18 (suppl 2):S14-S19.
32. Hayoz D, Nussberger J, Waeber B, Brunner HR: The renin-angiotensin system and arterial wall behavior. J Cardiovasc Pharmacol 1993, 22 (suppl 5):S48-S52.
33. Hahn AWA, Resink TJ, Kern F, Bühler FR: Peptide vasoconstrictors, vessel structure and vascular smooth-muscle proliferation. J Cardiovasc Pharmacol 1993, 22 (suppl 5):S37-S42.
34. Himeno H, Crawford DC, Hosoi M, Chobanian AV, Brecher P: Angiotensin II alters aortic fibronectin independently of hypertension. Hypertension 1994, 23:823-826.